|Articles|December 5, 2011
InterHealth Zychrome Beats Chromium in Insulin Management Study
Zychrome was deemed 1.4-fold and 2.0-fold more effective than chromium picolinate in controlling insulin levels and insulin functions respectively, according to the company.
Advertisement
InterHealth Nutraceuticals Inc. (Benicia, CA) reports that its patent-pending Zychrome brand chromium proved significantly more effective than standard chromium picolinate in a three-month clinical trial. Zychrome was deemed 1.4-fold and 2.0-fold more effective than chromium picolinate in controlling insulin levels and insulin functions respectively, according to the company.
InterHealth’s research was presented at the 52nd American College of Nutrition Meeting held November 16–19.
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Texas AG Launches Protein Powder Investigation Over Heavy Metal Contamination Concerns
2
FEMA GRAS Recognition Expands Regulatory Pathway for Layn Natural Ingredients’ Stevia Sweetener
3
From Sports Performance to Healthy Aging, Creatine Finds New Momentum
4
High-Dose Ashwagandha Root Extract Demonstrates Safety and Tolerability in Clinical Trial
5